All In Biotech

Drug Trial Radar · NCT02604914

A Sequential Two-Part, Open-Label Study in Healthy Male and Female Subjects

1) To Identify the Concentration of CD That Provides Optimal Bioavailability of a Concomitant Fixed Concentration of LD Infused SC Continuously; 2) To Compare the Bioavailability of the Optimal LD/CD Solution to That of LD/CD Intestinal Gel

Last checked: Nov 19, 2026Latest source record: Jan 18, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

36

Actual

Start

May 29, 2015

Primary completion

Jun 30, 2016

Study completion Jun 30, 2016

Sponsor

Lead sponsor
NeuroDerm Ltd.Industry
Sponsor type
Industry
Collaborators
Quotient Clinical
First posted
Nov 16, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 30 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

An Open-Label Study in Healthy Male and Female Subjects to Identify the Concentration that Provides Optimal Bioavailability of Levodopa Infused Subcutaneously via a Pump System; and to Compare the Bioavailability of Levodopa/Carbidopa Solution to that of Levodopa/Carbidopa Intestinal Gel (LCIG), Infused via a Naso-Jejunal Tube

Conditions

  • Parkinson's Disease

Interventions

  • ND0612Drug

    Subcutaneous solution

  • LCIGDrug

    Intrajejunal Gel

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cmax (maximal plasma concentration) of CD for different doses of CDTime frame: 6 days
  2. AUC (area under the curve) of CD for different doses of CDTime frame: 6 days
  3. Cmax (maximal plasma concentration) of LD and CD for ND0612 vs. LCIGTime frame: 4 days
  4. AUC (area under the curve) of LD and CD for ND0612. LCIGTime frame: 4 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Quotient Clinical LTD

    Ruddington, Nottingham, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.